This initial (after 4 h) antiglycolytic effect was followed, at a late post-PDT period (after 24 h), by significant PKM2 upregulation, thus highlighting the time-dependent regulatory role of ALA-PDT on cancer cell glycolysis [76]. The gene discussed is PKM; the disease is cancer.